US2021337252A1PendingUtilityA1

Means and Methods for Detecting Methylated DNA

Assignee: SEQUENOM INCPriority: Nov 29, 2004Filed: Dec 15, 2020Published: Oct 28, 2021
Est. expiryNov 29, 2024(expired)· nominal 20-yr term from priority
Inventors:Michael Rehli
C07K 14/4703C12Q 2537/164C07K 2319/00H04N 21/2401C07K 2319/20C07K 2319/30C07K 2319/80A61P 43/00H04N 21/2402C07K 2317/52C12Q 1/6886A61P 35/00
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present application relates to a nucleic acid molecule having a nucleotide sequence encoding a bifunctional polypeptide comprising the DNA-binding domain of a protein belonging to the family of Methyl-CpG binding proteins (MBDs) and the Fc portion of an antibody. In addition, vectors and host cells which comprise said nucleic acid molecule and polypeptides which are encoded by said nucleic acid molecule as well as processes for producing said polypeptide are disclosed. Moreover, the present application provides an antibody specifically binding said polypeptide and compositions, in particular diagnostic compositions comprising the nucleic acid molecule(s), vector(s), host cell(s), polypeptide(s) or antibodie(s) of the present application. Furthermore, methods and uses employing the polypeptides of the present invention for detecting methylated DNA, in particular in tumorous tissue or tumor cells are provided.

Claims

exact text as granted — not AI-modified
1 . A reagent for binding methylated DNA comprising:
 a first polypeptide and a second polypeptide each comprising: (i) a methyl-DNA-binding domain of an MBD2 protein; (ii) an Fc portion of an antibody and (iii) a flexible peptide linker, wherein the first polypeptide and second polypeptide each have the methyl-DNA-binding domain of the MBD2 protein fused to the Fc portion of an antibody through the flexible peptide linker and the Fc portion of an antibody of the first polypeptide is bonded to the Fc portion of an antibody of the second polypeptide; and   a bivalent binding site for methylated DNA comprising the methyl-DNA-binding domain of the first polypeptide in proximity to the methyl-DNA-binding domain of the second polypeptide, wherein the bivalent binding site can bind two methylated CpG residues that are on the same strand of a double stranded DNA molecule or on different strands of a double stranded DNA molecule.   
     
     
         2 . The reagent of  claim 1 , wherein the capacity to bind to methylated DNA is dependent on the degree of methylation. 
     
     
         3 . The reagent of  claim 1 , wherein the capacity to bind to methylated DNA is dependent on salt concentration. 
     
     
         4 . The reagent of  claim 1 , wherein the MBD2 protein is a human MBD2 protein. 
     
     
         5 . The reagent of  claim 1 , wherein the reagent can detect methylated DNA in a sample of less than 10 ng of genomic DNA. 
     
     
         6 . The reagent of  claim 1 , wherein the reagent can detect methylated DNA in a sample of less than 5 ng of genomic DNA. 
     
     
         7 . The reagent of  claim 1 , wherein the reagent can detect methylated DNA in a sample of less than 1 ng of genomic DNA. 
     
     
         8 . A composition comprising the reagent of  claim 1 .

Join the waitlist — get patent alerts

Track US2021337252A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.